The pharmacogenomics of sex hormone metabolism: breast cancer risk in menopausal hormone therapy

Author： Justenhoven Christina   Obazee Ofure   Brauch Hiltrud  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.6, 2012-04, pp. : 659-675

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Impact of Sex Hormone Metabolism on the Vascular Effects of Menopausal Hormone Therapy in Cardiovascular Disease

By  

Current Drug Metabolism, Vol. 11, Iss. 8, 2010-10 ,pp. : 693-714

Bentham Science Publishers

Access to resources Recommend Favorite

Menopausal hormone therapy: lower fracture risk, but at a cost?

By  

Reactions Weekly, Vol. 1, Iss. 1409, 2012-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Hormone therapy in peri- and postmenopause and the risk of cancer

By  

PHARMAKON, Vol. 3, Iss. 6, 2015-11 ,pp. : 455-459

Govi-Verlag

Access to resources Recommend Favorite

TIMP-1 predicts response to hormone therapy in breast cancer

By  

Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer

By Ligibel Jennifer A.   Winer Eric P.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 1, Iss. 2, 2003-04 ,pp. : 215-221

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite